These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 9920839)

  • 1. Association of a common polymorphism in the factor XIII gene with venous thrombosis.
    Catto AJ; Kohler HP; Coore J; Mansfield MW; Stickland MH; Grant PJ
    Blood; 1999 Feb; 93(3):906-8. PubMed ID: 9920839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Factor XIII Val34Leu variant is protective against venous thromboembolism: a HuGE review and meta-analysis.
    Wells PS; Anderson JL; Scarvelis DK; Doucette SP; Gagnon F
    Am J Epidemiol; 2006 Jul; 164(2):101-9. PubMed ID: 16740590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Factor XIII Val34Leu polymorphism, factor XIII antigen levels and activity and the risk of deep venous thrombosis.
    Van Hylckama Vlieg A; Komanasin N; Ariëns RA; Poort SR; Grant PJ; Bertina RM; Rosendaal FR
    Br J Haematol; 2002 Oct; 119(1):169-75. PubMed ID: 12358922
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor V R506Q mutation-Leiden: an independent risk factor for venous thrombosis but not coronary artery disease.
    Irani-Hakime N; Tamim H; Elias G; Choueiry S; Kreidy R; Daccache JL; Almawi WY
    J Thromb Thrombolysis; 2001 Apr; 11(2):111-6. PubMed ID: 11406725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorphisms in cancer patients with and without venous thrombosis.
    Ramacciotti E; Wolosker N; Puech-Leao P; Zeratti EA; Gusson PR; del Giglio A; Franco RF
    Thromb Res; 2003 Feb; 109(4):171-4. PubMed ID: 12757770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined carrier status of prothrombin 20210A and factor XIII-A Leu34 alleles as a strong risk factor for myocardial infarction: evidence of a gene-gene interaction.
    Butt C; Zheng H; Randell E; Robb D; Parfrey P; Xie YG
    Blood; 2003 Apr; 101(8):3037-41. PubMed ID: 12480694
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A common mutation in the gene for coagulation factor XIII-A (VAL34Leu): a risk factor for primary intracerebral hemorrhage is protective against atherothrombotic diseases.
    Gemmati D; Serino ML; Ongaro A; Tognazzo S; Moratelli S; Resca R; Moretti M; Scapoli GL
    Am J Hematol; 2001 Jul; 67(3):183-8. PubMed ID: 11391716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factor XIII Val34Leu polymorphism does not contribute to the prevention of thrombotic complications in patients with antiphospholipid syndrome.
    Diz-Kucukkaya R; Hancer VS; Inanc M; Nalcaci M; Pekcelen Y
    Lupus; 2004; 13(1):32-5. PubMed ID: 14870915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of factor XIII Val34Leu polymorphism in retinal artery occlusion.
    Weger M; Renner W; Stanger O; Schmut O; Deutschmann H; Wascher TC; Haas A
    Stroke; 2001 Dec; 32(12):2759-61. PubMed ID: 11739969
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prothrombin G20210A, factor V Leiden, and factor XIII Val34Leu: common mutations of blood coagulation factors and deep vein thrombosis in Austria.
    Renner W; Köppel H; Hoffmann C; Schallmoser K; Stanger O; Toplak H; Wascher TC; Pilger E
    Thromb Res; 2000 Jul; 99(1):35-9. PubMed ID: 10904101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The factor XIII Val34Leu polymorphism: is it protective against idiopathic venous thromboembolism?
    Wells PS; Anderson JL; Rodger MA; Carson N; Grimwood RL; Doucette SP
    Blood Coagul Fibrinolysis; 2006 Oct; 17(7):533-8. PubMed ID: 16988547
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of the prothrombin gene 20201 GA variant in FV:Q506 carriers in relationship to the presence or absence of juvenile venous thromboembolism.
    Ehrenforth S; von Depka Prondsinski M; Aygören-Pürsün E; Nowak-Göttl U; Scharrer I; Ganser A
    Arterioscler Thromb Vasc Biol; 1999 Feb; 19(2):276-80. PubMed ID: 9974407
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factor XIII Val34Leu is a genetic factor involved in the etiology of venous thrombosis.
    Franco RF; Reitsma PH; Lourenço D; Maffei FH; Morelli V; Tavella MH; Araújo AG; Piccinato CE; Zago MA
    Thromb Haemost; 1999 May; 81(5):676-9. PubMed ID: 10365735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The association between the Val34Leu polymorphism in the factor XIII gene and brain infarction.
    Elbaz A; Poirier O; Canaple S; Chédru F; Cambien F; Amarenco P
    Blood; 2000 Jan; 95(2):586-91. PubMed ID: 10627467
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.
    Almawi WY; Tamim H; Kreidy R; Timson G; Rahal E; Nabulsi M; Finan RR; Irani-Hakime N
    J Thromb Thrombolysis; 2005 Jun; 19(3):189-96. PubMed ID: 16082606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factor XIII Val34Leu variant and the risk of myocardial infarction: a meta-analysis.
    Shafey M; Anderson JL; Scarvelis D; Doucette SP; Gagnon F; Wells PS
    Thromb Haemost; 2007 Apr; 97(4):635-41. PubMed ID: 17393027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factor XIII polymorphisms and venous thromboembolism.
    Francis CW
    Arch Pathol Lab Med; 2002 Nov; 126(11):1391-3. PubMed ID: 12421147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The factor XIII-A Val34Leu polymorphism decreases whole blood clot mass at high fibrinogen concentrations.
    Kattula S; Bagoly Z; Tóth NK; Muszbek L; Wolberg AS
    J Thromb Haemost; 2020 Apr; 18(4):885-894. PubMed ID: 31989767
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The association between factor XIII Val34Leu polymorphism and early myocardial infarction.
    Hancer VS; Diz-Kucukkaya R; Bilge AK; Ozben B; Oncul A; Ergen G; Nalcaci M
    Circ J; 2006 Mar; 70(3):239-42. PubMed ID: 16501286
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factor V Leiden mutation carriership and venous thromboembolism in polycythemia vera and essential thrombocythemia.
    Ruggeri M; Gisslinger H; Tosetto A; Rintelen C; Mannhalter C; Pabinger I; Heis N; Castaman G; Missiaglia E; Lechner K; Rodeghiero F
    Am J Hematol; 2002 Sep; 71(1):1-6. PubMed ID: 12221665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.